Oscar Health (OSCR) Shares Outstanding (Weighted Average) (2020 - 2025)
Oscar Health (OSCR) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $262.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 9.15% year-over-year to $262.4 million, compared with a TTM value of $262.4 million through Dec 2025, up 9.15%, and an annual FY2025 reading of $262.4 million, up 9.15% over the prior year.
- Shares Outstanding (Weighted Average) was $262.4 million for Q4 2025 at Oscar Health, up from $259.3 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $262.4 million in Q4 2025 and bottomed at $88.9 million in Q1 2021.
- Average Shares Outstanding (Weighted Average) over 5 years is $219.4 million, with a median of $219.9 million recorded in 2023.
- The sharpest move saw Shares Outstanding (Weighted Average) skyrocketed 618.17% in 2021, then rose 1.63% in 2022.
- Year by year, Shares Outstanding (Weighted Average) stood at $179.0 million in 2021, then rose by 18.72% to $212.5 million in 2022, then increased by 4.32% to $221.7 million in 2023, then rose by 8.45% to $240.4 million in 2024, then grew by 9.15% to $262.4 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for OSCR at $262.4 million in Q4 2025, $259.3 million in Q3 2025, and $255.5 million in Q2 2025.